Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Pantoprazole (80mg) Dual Release Gastro-Resistant
Therapeutic Category
Gastroenterology, General and OTC medicines, Antacid
Dosage Form
Tablet
Packaging Type
Alu-Alu
Packaging
10x15
Price
₹271/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Panpital 80 DR Tablet contains Pantoprazole (80mg) in a dual-release gastro-resistant formulation. Pantoprazole is a proton pump inhibitor (PPI) that works by reducing the production of stomach acid, providing relief from acid-related disorders. This advanced dual-release technology ensures sustained efficacy by maintaining therapeutic levels for an extended period, making it effective for managing acid-related conditions.
Pantoprazole is commonly prescribed for conditions such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers. It is particularly beneficial in cases where rapid and sustained acid suppression is necessary. Panpital 80 DR Tablet helps alleviate symptoms like heartburn, acid reflux, and indigestion while promoting healing of acid-related damage in the stomach and esophagus.
This formulation is optimized to ensure that the medication reaches the target site in the stomach without being degraded by stomach acid, maximizing its therapeutic potential. The dual-release mechanism enhances patient compliance by offering a once-daily dosing regimen, reducing the frequency of administration.
Possible side effects include headache, nausea, diarrhea, abdominal pain, or flatulence.
Panpital 80 DR Tablet is indicated for GERD, peptic ulcers, Zollinger-Ellison syndrome, and other conditions requiring prolonged acid suppression.
Take as directed by your healthcare provider. Do not crush or chew the tablet, and complete the full prescribed course.
Store below 25°C in a cool, dry place, away from direct sunlight and moisture.
Composition : Pantoprazole (20mg)
Composition : Pantoprazole (40mg) Injection
Composition : Pantoprazole (40mg)
Composition : Cinitapride (3mg) + Pantoprazole (40mg)
Composition : Domperidone (10mg) + Pantoprazole (40mg)
Composition : Domperidone (30mg) + Pantoprazole (40mg)
Composition : Pantoprazole (E.C.) I.P. 40mg (E.C.) + Domperidone (I.R.) I.P. 10mg + Domperidone (S.R.) I.P. 20mg Capsules
Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Levosulpiride (75mg) + Pantoprazole (40mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Pantoprazole 80 mg Dual Release Gastro-Resistant Tablet is an advanced proton pump inhibitor (PPI) formulation used for the management of gastroesophageal reflux disease (GERD), acid reflux, erosive esophagitis, peptic ulcers, gastritis, and other acid-related gastrointestinal disorders. The dual-release gastro-resistant technology provides prolonged acid suppression and sustained symptom relief, making it a premium product in the gastroenterology segment.
Medical distributors and wholesalers can benefit from strong and continuous demand from gastroenterologists, physicians, and healthcare centers. Acid-related disorders are among the most commonly diagnosed conditions, and patients often require long-term therapy, ensuring consistent prescriptions, repeat purchases, and stable market demand.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in gastroenterology, general medicine, and chronic care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high prescription frequency, chronic therapy usage, and growing awareness of digestive health, making it a fast-moving, high-value, and repeat-prescription pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in gastroenterology and chronic care products can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the gastrointestinal healthcare segment.